INDUCTION THERAPY
Clinical trials for INDUCTION THERAPY explained in plain language.
Never miss a new study
Get alerted when new INDUCTION THERAPY trials appear
Sign up with your email to follow new studies for INDUCTION THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kidney transplant trial tests which drug better prevents rejection
Disease control Recruiting nowThis phase 3 trial compares two induction therapies—rabbit anti-thymocyte globulin (rATG) and basiliximab—in 244 sensitized kidney transplant recipients who do not have pre-existing donor-specific antibodies. The goal is to see which drug better prevents biopsy-proven acute rejec…
Matched conditions: INDUCTION THERAPY
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo aims to fight lung cancer after chemoradiation
Disease control Recruiting nowThis phase 2 trial is testing whether adding the drug QL1706 to standard chemotherapy and radiation can help people with limited-stage small cell lung cancer. QL1706 is a type of immunotherapy that targets two immune checkpoints to help the body fight cancer. The study will enrol…
Matched conditions: INDUCTION THERAPY
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC